Dysmetabolic iron overload syndrome (DIOS)

被引:61
|
作者
Deugnier, Yves [1 ,2 ,3 ]
Bardou-Jacquet, Edouard [1 ,2 ,3 ]
Laine, Fabrice [1 ,3 ]
机构
[1] CHU Rennes, Hop Pontchaillou, Ctr Reference Surcharges Genet Fer, Serv Malad Foie, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France
[2] Univ Rennes 1, Fac Med, F-35034 Rennes, France
[3] Hop Pontchaillou, INSERM, CIC1414, F-35033 Rennes, France
来源
PRESSE MEDICALE | 2017年 / 46卷 / 12期
关键词
NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE SYNDROME; SERUM FERRITIN; ADIPOSE-TISSUE; METABOLIC SYNDROME; TRANSFERRIN SATURATION; PHENOTYPIC-EXPRESSION; DISEASE; HEPCIDIN; HYPERFERRITINEMIA;
D O I
10.1016/j.lpm.2017.05.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.
引用
收藏
页码:E306 / E311
页数:6
相关论文
共 50 条
  • [41] Dietary iron overload enhances Western diet induced hepatic inflammation and alters lipid metabolism in rats sharing similarity with human DIOS
    Fujiwara, Sakura
    Izawa, Takeshi
    Mori, Mutsuki
    Atarashi, Machi
    Yamate, Jyoji
    Kuwamura, Mitsuru
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [42] Impact of hypertension on sympathetic nerve hyperactivity in the dysmetabolic syndrome
    Huggett, RJ
    Bannister, J
    Mackintosh, AF
    Mary, DASG
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 1A - 1A
  • [43] Iron overload due to mutations in ferroportin
    De Domenico, Ivana
    Ward, Diane McVey
    Musci, Giovanni
    Kaplan, Jerry
    HAEMATOLOGICA, 2006, 91 (01) : 92 - 95
  • [44] Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients
    Castiella, Agustin
    Urreta, Iratxe
    Zapata, Eva
    Zubiaurre, Leire
    Alustiza, Jose M.
    Otazua, Pedro
    Salvador, Emma
    Letamendi, Garazi
    Arrizabalaga, Beatriz
    Rincon, Maria L.
    Emparanza, Jose, I
    Iribarren, Arantxa
    Mendarte, Usua
    Bujanda, Luis
    Muro, Nerea
    Ibarra, Begona
    Dolores de Juan, M.
    de Juan, Aitor
    Leta-mendi, Garazi
    Luisa Rincon, Maria
    ANNALS OF HEPATOLOGY, 2020, 19 (01) : 31 - 35
  • [45] Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy
    Ellervik, C.
    Tybjaerg-Hansen, A.
    Appleyard, M.
    Ibsen, H.
    Nordestgaard, B. G.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (03) : 252 - 264
  • [46] Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies
    Taher, Ali
    Hershko, Chaim
    Cappellini, Maria Domenica
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (05) : 634 - 640
  • [47] Iron homeostasis in the Metabolic Syndrome
    Datz, Christian
    Felder, Thomas K.
    Niederseer, David
    Aigner, Elmar
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (02) : 215 - 224
  • [48] Serum ferritin is a biomarker for liver mortality in the Hemochromatosis and Iron Overload Screening Study
    Adams, Paul C.
    Barton, James C.
    Guo, Helen
    Alter, David
    Speechley, Mark
    ANNALS OF HEPATOLOGY, 2015, 14 (03) : 348 - 353
  • [49] Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?
    Coates, Thomas D.
    Carson, Susan
    Wood, John C.
    Berdoukas, Vasilios
    COOLEY'S ANEMIA, 2016, 1368 : 95 - 106
  • [50] IRON-DEFICIENCY AND IRON OVERLOAD IN SWEDISH MALE-ADOLESCENTS
    OLSSON, KS
    MARSELL, R
    RITTER, B
    OLANDER, B
    AKERBLOM, A
    OSTERGARD, H
    LARSSON, O
    JOURNAL OF INTERNAL MEDICINE, 1995, 237 (02) : 187 - 194